41 Items, 3 Pages <<Prev 1 2 3 Next>>
No. | ID | Biomarker Name | Name | Modification | Cancer Name | Application | Biomarker Type |
---|---|---|---|---|---|---|---|
21 | B0203 | combination of GATA5 and SFRP2 methylation (or) |
GATA5 SFRP2 |
methylation methylation |
colorectal cancer | blood | diagnosis |
22 | B0206 | combination of SNCA and FBN1 methylation |
SNCA FBN1 |
methylation methylation |
colorectal cancer | stool | diagnosis |
23 | B0228 | methylation of IRF4, FOXE-1, AOX-1, ADAMTS9 and RERG |
IRF4 FOXE-1 AOX-1 ADAMTS9 RERG |
methylation methylation methylation methylation methylation |
colorectal cancer | blood | diagnosis |
24 | B0249 | hypermethylation of miR-34b/c |
hsa-miR-34b-3p hsa-miR-34c-5p |
methylation methylation |
colorectal cancer | stool | diagnosis |
25 | B0252 | methylation of miR-34b/c |
hsa-miR-34b-3p hsa-miR-34c-5p |
methylation methylation |
colorectal cancer | stool | diagnosis |
26 | B0255 | combination of miR137 and IGFBP3 hypermethylation |
IGFBP3 hsa-miR-137 |
methylation methylation |
colorectal cancer | tissue | diagnosis |
27 | B0258 | epigenetic silencing of miR-181b |
hsa-miR-181b-5p |
methylation |
colorectal cancer | tissue | diagnosis, prognosis |
28 | B0260 | combination of miR-124-3, ZNF582-AS1 and SFRP1 methylation |
ZNF582-AS1 SFRP1 hsa-miR-124-3 |
methylation methylation methylation |
colorectal cancer | bowel lavage fluid | diagnosis |
29 | B0282 | combination of seven hypermethylated promoter regions (ALX4, BMP3, NPTX2, RARB, SDC2, SEPT9, and VIM) |
ALX4 BMP3 NPTX2 RARB SDC2 SEPT9 VIM |
methylation methylation methylation methylation methylation methylation methylation |
colorectal cancer | tissue | diagnosis |
30 | B0283 | methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 |
SFRP1 SFRP2 SDC2 PRIMA1 |
methylation methylation methylation methylation |
colorectal cancer | blood | diagnosis |
31 | B0284 | methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 |
SFRP1 SFRP2 SDC2 PRIMA1 |
methylation methylation methylation methylation |
colorectal cancer | blood | diagnosis |
32 | B0288 | combination of CMTM3, SSTR2 and MDFI methylation |
CMTM3 SSTR2 MDFI |
methylation methylation methylation |
colorectal cancer | tissue | diagnosis |
33 | B0305 | combination of MGMT, RASSF1A and SEPT9 methylation |
MGMT RASSF1A SEPT9 |
methylation methylation methylation |
colorectal cancer | tissue | diagnosis |
34 | B0311 | five-gene methylation panel(EYA4, GRIA4, ITGA4, MAP3K14-AS1, MSC) |
EYA4 GRIA4 ITGA4 MAP3K14-AS1 MSC |
methylation methylation methylation methylation methylation |
colorectal cancer | blood | treatment |
35 | B0326 | combination of hypermethylation of CDKN2A exon 1 and exon 2 |
CDKN2A CDKN2A |
methylation methylation |
colorectal cancer | tissue | diagnosis |
36 | B0347 | combination of methylated SEPTIN9 and/or SDC2 |
SEPTIN9 SDC2 |
methylation methylation |
colorectal cancer | tissue | diagnosis |
37 | B0348 | a classification model built with methylation of SDC2 and SFRP2, KRAS mutations and hemoglobin |
SDC2 SFRP2 |
methylation methylation |
colorectal cancer | stool | diagnosis |
38 | B0349 | combination of the methylation statuses of NKX6.1, LMX1A, SOX1, and ZNF177 |
NKX6-1 LMX1A SOX1 ZNF177 |
methylation methylation methylation methylation |
colorectal cancer | tissue | prognosis |
39 | B0350 | combination of methylation of SEPT9, NDRG4, and SDC2 |
SEPTIN9 NDRG4 SDC2 |
methylation methylation methylation |
colorectal cancer | stool | diagnosis |
40 | B0359 | combination of methylation of C9orf50, KCNQ5, and CLIP4 |
C9orf50 KCNQ5 CLIP4 |
methylation methylation methylation |
colorectal cancer | stool | diagnosis |